Treatment of tumour-induced hypercalcaem
✍
Z. Neškovié-Konstantinovié; L. Mitrovié; J. Petrovié; L. Stamatovié; Z. Ristovié
📂
Article
📅
1995
🏛
Springer-Verlag
🌐
English
⚖ 312 KB
A group of 38 female patients with advanced breast cancer experiencing the first occurrence of tumour-induced hypercalcaemia (TIH), mostly with osteolytic progressive bone metastases, were included in a prospective calcaemiaadapted study using three different doses of pamidronate (30 mg, 45 mg and 6